Cell Line Characterization

BioReliance CRO’s cell line characterization services enable production of biologicals free of molecular, cellular, and viral contamination. We offer a wide variety of cell line characterization services including:

  • Sterility testing (mycobacterium and sterility assays)
  • Mycoplasma detection
  • Adventitious agents/ Virology Testing (adventitious virus, in vivo and in vitro assays, 9 CFR, transmission electron microscopy, MAP test)
  • Cell line authentication (CO1 barcode assay, DNA analysis, RAPD Karyotyping)
  • Genetic stability (cell lines and cell banks: FISH, DNA sequencing, Next Generation Sequencing)
  • Oncogenicity and tumorigenicity

We suggest performing cell line characterization studies on both mammalian and non-mammalian cell lines for our customers in various stages of drug production including:

  • Cell lines
  • Working cell banks
  • Master cell banks
  • End-of-production cells (EOPC)
  • Virus seed stock
  • Raw materials and final products

Custom services also are available. Contact BioReliance and our research team will be happy to assist you in planning your cell line characterization studies. Below you will find more information about the regulatory guidelines we support.

Regulatory Guidelines for Cell Characterization

BioReliance CRO scientists will assist you in designing your cell line characterization studies in compliance with global current Good Manufacturing Practice (cGMP), Good Laboratory Practice (GLP) practices as well as FDA and international regulatory guidelines.

The regulatory requirements for a cell line or virus seed characterization program have three major components:

  • Source history and generation of the cell line or virus seed
  • Characterization and testing to establish identity, purity and stability
  • Cell banking or virus seed banking procedures

If the product is to be marketed internationally, then initial efforts should be placed on developing cell line characterization and testing programs that satisfy regulatory requirements and recommendations of the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA) and Japanese Ministry of Health, Labour and Welfare.

BioReliance has manufactured and characterized hundreds of client cell banks and offers a complete testing program. Programs are custom designed to take into account the species of origin and culture history of the cells. Click here to contact us for your cell line characterization needs.

Contact Us: 1.800.756.5658

Search Sigma-Aldrich.com

Sigma aldrich

Copyright © 2017 Sigma-Aldrich Co. LLC.  All Rights Reserved. Reproduction of any materials from the site is strictly forbidden without permission.  Sigma-Aldrich brand products are sold exclusively through Sigma-Aldrich Co. LLC. Sigma-Aldrich Corp. is a subsidiary of Merck KGaA, Darmstadt, Germany  Terms | Privacy | Site Map